Back to Article List

Low-risk determination for marketing of products, including genome-edited foods

USA

Mar 09, 2022

The U.S. Food and Drug Administration announced it has made a low-risk determination for the marketing of products, including food, from two genome-edited beef cattle and their offspring after determining that the intentional genomic alteration (IGA) does not raise any safety concerns (low-risk determination). The IGA results in the equivalent genotype (genetic make-up) and short-hair coat trait seen in some conventionally bred cattle, known as a “slick” coat. This is the FDA’s first low-risk determination for enforcement discretion for an IGA in an animal for food use. 

For further information (in English), click on the Link

Share:

Tags:

Related Articles
See All News
Subscribe to our newsletter

The best industry insight in your mailbox